Language:
Daily summary of financings for therapeutic biotechnology company executives and investors
Monday, November 17, 2025
J&J’s $3.05 Billion Acquisition of Halda Therapeutics
Inventiva’s $173 Million Public Offering
Solve’s $120 Million Venture Financing…MoreMore
Artios’s $115 Million Series D…MoreMore
Sunday, November 16, 2025
Sofinnova Partner’s $753 Million Fund Raise
Friday, November 14, 2025
Annexon’s $86 Million Public Offering
Scripta’s $12 Million Fund Raise
Thursday, November 13, 2025
Day One’s $285 Million Acquisition of Mersana
Inventiva’s $150 Million Public Offering
enGene’s $130 Million Public Offering
AEON’s $22 Million Private Placement
Virometix’s $15 Million Financing Round
NurExone’s $2 Million Warrant Exercise
Wednesday, November 12, 2025
Biohaven’s $175 Million Public Offering
Centessa’s $250 Million Public Offering
Annexon’s $75 Million Public Offering
Eledon’s $50 Million Public Offering
NextCure’s $22 Million Private Placement
Modulight’s $12 Million Seed Round
ThirdLaw’s $6 Million Seed Round
Tuesday, November 11, 2025
Cogent’s $200 Million Public Offering
INOVIO’s $25 Million Public Offering
NanoViricides’s $6 Million Registered Direct Offering and Private Placement
Allurion’s $5 Million Private Placement
Monday, November 10, 2025
Galecto’s $285 Million Acquisition of Damora
Vor Bio’s $100 Million Public Offering
Propanc’s $100 Million Private Placement
Friday, November 7, 2025
Halozyme’s $650 Million Debt Financing
Billion to One’s $314 Million IPO
Pelthos’s $18 Million Debt Financing
Pfizer’s Merger with Metsera…More
Thursday, November 6, 2025
Benitec’s $100 Million Registered Direct Offering
4DMT’s $100 Million Pre-Funded Warrants
Palatin’s $16 Million Public Offering
Wednesday, November 5, 2025
Braveheart’s $185 Million Series A
PNP Program Partners
In coordination with an executive placement firm that is independent and unaffiliated with Collabrity, Inc., we may coordinate with executive(s) who are sourced by that firm and also independent and unaffiliated with Collabrity, Inc.: “Collabrity Executive(s)” does not imply an employment or independent contractor relationship with Collabrity, Inc.
Securities offered through Finalis Securities LLC Member FINRA / SIPC. Collabrity Inc. is not a registered broker-dealer, and Finalis Securities LLC and Collabrity Inc. are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck